News
![]() |
Primer Capital Founders featured in Forbes3 December 2019 Primer Capital founders, Dmitry Sharov and Timur Avdeenko shared the story of the fund in a feature story by Forbes Russia.
|
![]() |
Primer Capital Founders featured in Forbes Primer Capital founders, Dmitry Sharov and Timur Avdeenko shared the story of the fund in a feature story by Forbes Russia.
|
![]() |
Primer Capital at the III International Medical Investment Forum28 November 2019 Primer Capital COO Elizaveta Rozhdestvenskaya spoke at the round table on Investing in Science during the III International Medical Investment Forum 2019.
|
![]() |
Primer Capital at the III International Medical Investment Forum Primer Capital COO Elizaveta Rozhdestvenskaya spoke at the round table on Investing in Science during the III International Medical Investment Forum 2019.
|
![]() |
Primer Capital's porfolio project, raises €7M in addtion to its Series B6 November 2019 Acticor Biotech, Primer Capital's portfolio unit, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including acute ischemic stroke, today announced that it has raised €7 million in addition to its Series B which is now completed at €22,3 million.
|
![]() |
Primer Capital's porfolio project, raises €7M in addtion to its Series B Acticor Biotech, Primer Capital's portfolio unit, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including acute ischemic stroke, today announced that it has raised €7 million in addition to its Series B which is now completed at €22,3 million.
|
![]() |
With luck it takes at least seven years for the product to enter the market23 October 2019 In her interview for Rusbase Primer Capital COO Elizaveta Rozhdenstvenskaya shared her thoughts on the pharma and biotech startups and the overall venture market trends.
|
![]() |
With luck it takes at least seven years for the product to enter the market In her interview for Rusbase Primer Capital COO Elizaveta Rozhdenstvenskaya shared her thoughts on the pharma and biotech startups and the overall venture market trends.
|
![]() |
Primer Capital CEO speaking at the round table by the Analytics Center for the Government of the Russian Federation30 September 2019 Anton Lavrentev took part in the discussion on the “Direct and Venture Investment Funds as a Key Tool in Financing Digital Economy” held by the Analytics Center for the Government of the Russian Federation.
|
![]() |
Investing in the development of a drug that eliminates the consequences of neurodegenerative diseases11 September 2019 Primer Capital Venture Fund invested in a US-based company. The startup’s unique technology allows to halt the development of the short memory impairment that is characteristic of the patients with various neurodegenerative diseases. The portfolio of Primer Capital now includes 11 projects from Russia, USA, Israel and France.
|
![]() |
How can a venture fund assist in drug development?20 August 2019 Primer Capital investment analyst Sofia Yartseva elaborated on the role of venture investments in drug development process and its further marketing.
|
![]() |
How can a venture fund assist in drug development? Primer Capital investment analyst Sofia Yartseva elaborated on the role of venture investments in drug development process and its further marketing.
|
![]() |
Primer Capital ranked #1 among Biotech Venture Funds in Europe12 August 2019 Primer Capital has been awarded the Best Biotech VC Fund – Europe by Wealth & Money Management Awards 2019.
|
![]() |
Primer Capital ranked #1 among Biotech Venture Funds in Europe Primer Capital has been awarded the Best Biotech VC Fund – Europe by Wealth & Money Management Awards 2019.
|
![]() |
Portfolio unit's founder ranked among top 20 medtech entrepreneurs10 July 2019 The founder of Data MATRIX (Primer Capital's portfolio project) entered the ranking of the top 20 most successful MedTech entrepreneurs according to RusBase.
|
![]() |
Portfolio unit's founder ranked among top 20 medtech entrepreneurs The founder of Data MATRIX (Primer Capital's portfolio project) entered the ranking of the top 20 most successful MedTech entrepreneurs according to RusBase.
|
![]() |
Primer Capital Experts on Ethical Investment5 July 2019 Anton Lavrentev, head of the legal department at Primer Capital, in his interview for VC.ru talked about ethical components which are essential for investors to consider before taking on new target.
|
![]() |
Primer Capital Experts on Ethical Investment Anton Lavrentev, head of the legal department at Primer Capital, in his interview for VC.ru talked about ethical components which are essential for investors to consider before taking on new target.
|
Записи 1 - 10 of 55
First | Prev. | 1 2 3 4 5 | Next | Last